Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01957891 · ClinicalTrials.gov registry record
Hypoxia at Multiple Wavelengths of Light
A clinical trial, sponsored by Nonin Medical.
- Completed
- Registry status
- 26
- Enrollment target
NCT01957891: Completed study, sponsored by Nonin Medical.
NCT01957891 is a clinical trial that has completed, run by Nonin Medical. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01957891 has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the effect of progressive, incremental hypoxia at multiple wavelengths of light.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-02 |
What the finished NCT01957891 record still lists
NCT01957891 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01957891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01957891 about?
NCT01957891 is a clinical study titled "Hypoxia at Multiple Wavelengths of Light". The purpose of the study is to assess the effect of progressive, incremental hypoxia at multiple wavelengths of light.
What is the current status of trial NCT01957891?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2013-09. Estimated completion is 2014-02.
Who is sponsoring clinical trial NCT01957891?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia